KD Pharma Bexbach GmbH has been providing high purity omega-3 fatty acid concentrates for over 25 years. Specialists in separation techniques, founders Rudolf Krumbholz and Michael Dorsheid focused their early efforts on improving the quality and sensory aspects of Omega-3 fish oil, long before Omega-3 became one of the fastest growing sectors of the natural health products industry.
Early work led to the development of KD Pharma’s patented process based on Super Critical Fluid (SCF) technology. SCF consists of two processes: Supercritical Fluid Extraction (SFE) and Supercritical Fluid Chromatography (SFC), both of which gently extract and purify Polyunsaturated Fatty Acids (PUFA’s) from fish oil. This SFC technology can also be applied to oils from various other sources. Today, KD Pharma has multiple state-of-the-art purification technologies. This flexibility to combine technologies has made KD Pharma the global leader in Omega-3 production.
KD Pharma has developed extensive experience with the analysis of Omega-3 oils and a broad portfolio of analytic methods available for in-house lipid analyses. Analyses includes determination of fatty acid ratios, lipid class analysis as well as total fatty acid compositions.
KD Pharma is well equipped for development projects and guidance by leveraging its wide network of clients and suppliers, membership in trade associations (ie., GOED, DGF), established global distribution chain and regulatory affairs competence.